We report a case of a newborn infant whose mother had systemic lupus erythematosus (SLE) diagnosed before pregnancy.
Neonatal lupus erythematosus (NLE), characterised by congenital atrioventricular heart block or transient lupus skin lesions or both,' is considered to be caused by passively acquired autoimmunity via the placenta.2 In addition, the use of oral anticoagulants between 6 and 9 weeks of gestation can cause congenital abnormalities, consisting of intrauterine growth retardation (IUGR), hypotonia, craniofacial abnormalities with a hypoplastic nose, chondrodysplasia punctata (stippled epiphyses), hypoplastic nails, and other manifestations. 3'4 In this report we present a patient with neonatal lupus with uncommon manifestations ressembling both syndromes. Laboratory tests showed anaemia, leucopenia, (+) ANA, (+) anti-ds DNA, hypocomplementaemia, (+) anticardiolipin antibodies, IgG, and (-) lupic anticoagulant. She discontinued all medication after the third month of pregnancy. At 33 weeks a female was born by caesarean section because of acute fetal distress and IUGR. Apgar scores were 8 and 9 at one and five minutes respectively, birth weight was 1500 g, and length 39.5 cm. The placenta showed multiple infarctions. Two weeks after delivery, the mother had a severe lupic crisis with (+) anti-Ro antibodies, (+) ANA, severe hypocomplementaemia, high levels of anticardiolipin IgG antibodies, and positive lupic anticoagulant, which was negative at the beginning of the pregnancy. Protein C and S were in the normal range.
CLINICAL MANIFESTATIONS
The child had facial dysmorphism consisting of poorly developed brow ridges, depressed nasal bridge and nasal hypoplasia, large philtrum, thin pinnae, and a prominent occiput. Skin lesions consisted of small, 0.5 cm annular plaques limited to the face, around the lateral sides of the orbits in an almost symmetrical distribution. The lesions were erythematoviolaceous, scaling, and depressed (fig 1) . Histology of a skin lesion showed orthokeratosis, normal thickness for age, and slightly spongy epidermis. There was superficial and perifollicular lymphocytic and histiocytic infiltration, epidermal focal vacuolar alteration, and scanty, apoptotic keratinocytes. Direct immunofluorescence was positive for C3, C4, IgG, fibrin, and superficial dermal globules (apoptotic bodies). The extremities showed nail hypoplasia, especially on the B Figure 1 (A, B) Skin lesions, consisting of small annular plaques around the lateral side of the orbit, andfacial dysmorphism, consisting ofpoorly developed brow ridges, depressed nasal bridge, and nasal hypoplasia, in the patient with neonatal lupus. Osteochondrodysplasia punctata was present in the sacrococcygeal region and in both heels (fig 2) , but not in any other part of the skeleton. The rest of the radiological study was normal. Echography of the skull was normal.
Discussion
We present a patient with neonatal lupus who has a spectrum of clinical manifestations not previously reported to be part of the clinical description of this disease. Chondrodysplasia punctata, one of the anomalous symptoms found in this patient, occurs in numerous inherited conditions and as a consequence of the use of some teratogens, like warfarin or derivatives. 5 Some of the clinical findings in this patient are similar to congenital anomalies usually related to the use of oral anticoagulants. Because in this case the patient had no previous exposure, an alternative mechanism is suggested which produces the same effect as the anticoagulants. The calcium binding capacity of various proteins can be reduced by interference ofvitamin K dependent post-translational carboxylation of glutamil residues by oral anticoagulants.6 During a critical period of ossification in embryonic development, the inhibition of these calcium binding proteins by these drugs could explain the craniofacial anomalies and stippled calcification, as well as other manifestations. 4 In this case, neonatal lupus could also involve an affected calcium binding protein. which is not present here. We can also discard malabsorptive vitamin K deficiency secondary to maternal bowel disorder, which has recently been described as vitamin K deficiency embryopathy. None of the drugs prescribed to the mother before or during pregnancy have been reported to have this kind of teratogenic effect.
Antiphospholipid antibodies have also been related to neonatal lupus manifestations. The presence of both anticardiolipin antibodies and lupic anticoagulant at the end of this pregnancy could explain findings such as thrombocytopenia, IUGR, prematurity, and a placenta with multiple infarctions.13 -15 We suggest that it is advisable for every newborn baby suspected of having neonatal lupus to have a radiological examination of the skeleton to discard the presence of osteochondrodysplasia punctata lesions.
